Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - COMMON STOCK
Common Stock KALV - KalVista Pharmaceuticals, Inc.
42 K
LAST VALUE
29.61%
2 YEAR CAGR
19.83%
5 YEAR CAGR
35.59%
10 YEAR CAGR